KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Dividends Paid - Common (2016 - 2025)

Abbott Laboratories' Dividends Paid - Common history spans 17 years, with the latest figure at $1.0 billion for Q4 2025.

  • For Q4 2025, Dividends Paid - Common rose 7.52% year-over-year to $1.0 billion; the TTM value through Dec 2025 reached $4.1 billion, up 7.3%, while the annual FY2025 figure was $4.1 billion, 7.3% up from the prior year.
  • Dividends Paid - Common for Q4 2025 was $1.0 billion at Abbott Laboratories, roughly flat from $1.0 billion in the prior quarter.
  • Across five years, Dividends Paid - Common topped out at $1.0 billion in Q3 2025 and bottomed at $798.0 million in Q4 2021.
  • The 5-year median for Dividends Paid - Common is $889.0 million (2023), against an average of $901.0 million.
  • The largest annual shift saw Dividends Paid - Common increased 25.39% in 2021 before it grew 3.11% in 2022.
  • A 5-year view of Dividends Paid - Common shows it stood at $798.0 million in 2021, then increased by 3.13% to $823.0 million in 2022, then increased by 7.9% to $888.0 million in 2023, then grew by 7.88% to $958.0 million in 2024, then rose by 7.52% to $1.0 billion in 2025.
  • Per Business Quant, the three most recent readings for ABT's Dividends Paid - Common are $1.0 billion (Q4 2025), $1.0 billion (Q3 2025), and $1.0 billion (Q2 2025).